Work

Diltiazem-associated Photodistributed Hyperpigmentation.

Year: 2020

Type: article

Abstract: Diltiazem is a calcium-channel blocker commonly used for the treatment of hypertension. Common adverse effects include dizziness, headache, and edema. Fewer than 20 cases of diltiazem-associated photodistributed hyperpigmentation have been reported in the literature. Here, we present the case of a 71-year-old woman with new-onset facial hyperpigmentation 6 months after initiating treatment with diltiazem.

Source: PubMed

Authors: Jacob D Siegel, Christine J Ko

Institution: Yale University

Language: English

Topic: melanin and skin pigmentation

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3013512694

FWCI: 0.889

Cites: 15

Cited by: 12

Related to: 10